The detailed clinical results, mechanism of action, preclinical efficacy, and safety profile of Maizinol™ will be presented.

Cassie Smith

November 12, 2021

A double-blind placebo-controlled clinical trial on sleep quality and overall wellbeing was carried out on 45 healthy adults for a clinically confirmed mood enhancing, Zea mays leaf-derived, and patented ingredient: Maizinol™. A statistically significant and dose-correlated increase of approximately 30% deep sleep time, improvement of sleep quality and reduction of salivary cortisol were observed. The detailed clinical results, mechanism of action, preclinical efficacy and safety profile of Maizinol™ will be presented.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like